Motif ID: Chd1_Pml
Z-value: 4.204
Transcription factors associated with Chd1_Pml:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Chd1 | ENSMUSG00000023852.7 | Chd1 |
| Pml | ENSMUSG00000036986.10 | Pml |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Pml | mm10_v2_chr9_-_58249660_58249672 | -0.43 | 1.2e-03 | Click! |
| Chd1 | mm10_v2_chr17_+_15704963_15704994 | -0.12 | 3.9e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 21.2 | 63.6 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 16.0 | 48.0 | GO:0060596 | mammary placode formation(GO:0060596) |
| 15.7 | 47.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 13.1 | 39.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 12.6 | 75.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 10.8 | 32.5 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 10.8 | 32.3 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 8.9 | 44.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 8.6 | 25.9 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 8.6 | 34.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 8.6 | 34.5 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 8.2 | 8.2 | GO:0030818 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
| 8.1 | 8.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 8.1 | 40.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 7.7 | 38.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 7.6 | 30.4 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 7.5 | 7.5 | GO:2000830 | vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 7.4 | 22.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 7.4 | 14.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 7.2 | 21.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 7.0 | 27.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 6.9 | 110.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 6.9 | 13.7 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 6.9 | 6.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 6.8 | 6.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 6.6 | 13.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 6.3 | 12.6 | GO:0061744 | motor behavior(GO:0061744) |
| 6.3 | 18.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 6.3 | 94.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 6.2 | 37.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 6.2 | 18.5 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 6.1 | 24.6 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 6.1 | 109.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 6.1 | 24.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 5.9 | 29.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 5.9 | 23.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 5.7 | 17.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 5.7 | 5.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 5.6 | 33.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 5.5 | 33.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 5.5 | 21.9 | GO:0021586 | pons maturation(GO:0021586) |
| 5.4 | 27.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 5.2 | 36.6 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 5.2 | 20.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 5.2 | 20.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 5.1 | 15.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 5.1 | 51.1 | GO:0046959 | habituation(GO:0046959) |
| 5.0 | 25.0 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 5.0 | 15.0 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 5.0 | 15.0 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 5.0 | 5.0 | GO:0007172 | signal complex assembly(GO:0007172) |
| 5.0 | 9.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 4.9 | 14.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 4.9 | 29.4 | GO:0009405 | pathogenesis(GO:0009405) |
| 4.9 | 19.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 4.9 | 14.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 4.8 | 24.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 4.8 | 19.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 4.7 | 33.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 4.7 | 56.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 4.7 | 9.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 4.7 | 18.7 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 4.7 | 4.7 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 4.5 | 35.9 | GO:0097264 | self proteolysis(GO:0097264) |
| 4.5 | 40.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 4.5 | 4.5 | GO:0097324 | melanocyte migration(GO:0097324) |
| 4.4 | 22.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 4.4 | 4.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 4.3 | 13.0 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 4.3 | 13.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 4.3 | 30.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 4.3 | 12.8 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 4.2 | 17.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 4.2 | 8.4 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 4.2 | 21.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 4.1 | 12.3 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 4.1 | 12.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 4.1 | 61.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 4.0 | 16.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 4.0 | 20.1 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 4.0 | 4.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
| 4.0 | 35.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 3.9 | 7.9 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 3.9 | 19.5 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 3.9 | 39.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 3.9 | 11.6 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
| 3.8 | 22.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 3.8 | 11.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 3.8 | 11.3 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 3.7 | 11.2 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 3.7 | 29.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 3.7 | 11.0 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 3.7 | 14.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 3.6 | 10.9 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
| 3.6 | 18.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 3.6 | 3.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 3.6 | 18.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 3.6 | 18.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 3.6 | 10.7 | GO:0007525 | somatic muscle development(GO:0007525) |
| 3.6 | 3.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 3.5 | 21.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 3.5 | 56.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 3.5 | 10.6 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 3.5 | 3.5 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 3.5 | 14.0 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 3.5 | 10.5 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 3.5 | 10.5 | GO:0015866 | ADP transport(GO:0015866) |
| 3.5 | 24.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 3.4 | 13.7 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 3.4 | 17.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 3.4 | 10.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 3.4 | 17.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 3.4 | 17.0 | GO:1901660 | calcium ion export(GO:1901660) |
| 3.4 | 44.0 | GO:0070842 | aggresome assembly(GO:0070842) |
| 3.4 | 3.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 3.4 | 10.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 3.3 | 3.3 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 3.3 | 26.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 3.3 | 10.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 3.3 | 39.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 3.3 | 26.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 3.3 | 49.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 3.3 | 13.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 3.2 | 32.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 3.2 | 25.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 3.2 | 48.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 3.2 | 12.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 3.2 | 19.2 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 3.2 | 22.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 3.2 | 19.0 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 3.2 | 15.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 3.2 | 9.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 3.1 | 31.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 3.1 | 3.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 3.1 | 9.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 3.1 | 9.4 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 3.1 | 9.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 3.1 | 9.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 3.1 | 12.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 3.0 | 18.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 3.0 | 3.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 3.0 | 12.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 3.0 | 18.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 3.0 | 12.0 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
| 3.0 | 14.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 3.0 | 17.8 | GO:0019695 | choline metabolic process(GO:0019695) |
| 2.9 | 35.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 2.9 | 8.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.9 | 2.9 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
| 2.9 | 5.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 2.9 | 8.7 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 2.9 | 11.5 | GO:0015871 | choline transport(GO:0015871) |
| 2.9 | 11.5 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 2.9 | 5.7 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
| 2.8 | 11.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 2.8 | 2.8 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 2.8 | 31.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 2.8 | 2.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 2.8 | 11.1 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 2.8 | 11.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 2.8 | 2.8 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 2.8 | 16.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 2.8 | 2.8 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 2.8 | 8.3 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 2.8 | 5.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 2.7 | 73.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 2.7 | 13.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 2.7 | 27.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 2.7 | 29.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 2.7 | 8.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 2.7 | 24.1 | GO:0014850 | response to muscle activity(GO:0014850) |
| 2.7 | 5.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 2.6 | 15.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 2.6 | 5.3 | GO:0071625 | vocalization behavior(GO:0071625) |
| 2.6 | 13.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 2.6 | 26.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 2.6 | 15.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.6 | 7.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.6 | 7.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 2.6 | 2.6 | GO:0060003 | copper ion export(GO:0060003) |
| 2.6 | 10.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 2.6 | 5.1 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 2.5 | 7.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.5 | 10.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 2.5 | 10.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
| 2.5 | 35.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 2.5 | 12.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 2.5 | 42.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 2.5 | 7.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 2.5 | 7.5 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 2.5 | 5.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 2.5 | 2.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
| 2.5 | 14.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 2.5 | 7.4 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 2.5 | 2.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of glutamate metabolic process(GO:2000211) |
| 2.5 | 17.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 2.4 | 29.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 2.4 | 29.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 2.4 | 7.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 2.4 | 7.2 | GO:0016598 | protein arginylation(GO:0016598) |
| 2.4 | 7.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 2.4 | 7.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 2.4 | 2.4 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 2.4 | 4.8 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 2.4 | 4.7 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 2.4 | 14.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 2.4 | 4.7 | GO:1901419 | regulation of vitamin D receptor signaling pathway(GO:0070562) regulation of response to alcohol(GO:1901419) |
| 2.4 | 7.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 2.3 | 9.4 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 2.3 | 4.7 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 2.3 | 2.3 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 2.3 | 6.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 2.3 | 16.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 2.3 | 11.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.3 | 22.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 2.3 | 20.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 2.3 | 16.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 2.3 | 11.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.3 | 22.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 2.3 | 54.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 2.3 | 4.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 2.2 | 9.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 2.2 | 33.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 2.2 | 4.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 2.2 | 11.0 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 2.2 | 19.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 2.2 | 6.6 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 2.2 | 15.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 2.2 | 8.7 | GO:0051775 | response to redox state(GO:0051775) |
| 2.2 | 36.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 2.2 | 2.2 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
| 2.2 | 4.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 2.1 | 6.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 2.1 | 12.8 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 2.1 | 29.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 2.1 | 6.4 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.1 | 17.0 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 2.1 | 10.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 2.1 | 12.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 2.1 | 2.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
| 2.1 | 6.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 2.1 | 4.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 2.1 | 6.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 2.1 | 4.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 2.1 | 8.3 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 2.1 | 4.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 2.1 | 6.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 2.1 | 12.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 2.1 | 6.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 2.1 | 14.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 2.1 | 26.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 2.1 | 6.2 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 2.1 | 12.3 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 2.0 | 14.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 2.0 | 4.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 2.0 | 6.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 2.0 | 18.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 2.0 | 12.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 2.0 | 8.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 2.0 | 148.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 2.0 | 2.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 2.0 | 14.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 2.0 | 8.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 2.0 | 4.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
| 2.0 | 5.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 2.0 | 9.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 2.0 | 3.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 2.0 | 7.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 2.0 | 5.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 1.9 | 5.8 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.9 | 5.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 1.9 | 3.9 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
| 1.9 | 1.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 1.9 | 9.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 1.9 | 5.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 1.9 | 9.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 1.9 | 11.5 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 1.9 | 13.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.9 | 5.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 1.9 | 11.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 1.9 | 30.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 1.9 | 9.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.9 | 5.7 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 1.9 | 9.4 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 1.9 | 1.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 1.9 | 9.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 1.8 | 1.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 1.8 | 5.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
| 1.8 | 5.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 1.8 | 1.8 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.8 | 1.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 1.8 | 1.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 1.8 | 5.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.8 | 5.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.8 | 18.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 1.8 | 45.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 1.8 | 5.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 1.8 | 5.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.8 | 12.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 1.8 | 10.8 | GO:0006477 | protein sulfation(GO:0006477) |
| 1.8 | 5.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.8 | 3.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 1.8 | 3.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 1.8 | 3.6 | GO:1903912 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 1.8 | 8.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 1.8 | 5.3 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 1.7 | 6.9 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.7 | 26.0 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 1.7 | 1.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 1.7 | 10.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 1.7 | 3.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.7 | 10.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.7 | 5.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 1.7 | 1.7 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 1.7 | 22.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 1.7 | 5.1 | GO:0045576 | mast cell activation(GO:0045576) |
| 1.7 | 6.8 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 1.7 | 10.2 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 1.7 | 8.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.7 | 10.2 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 1.7 | 5.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) retrograde trans-synaptic signaling(GO:0098917) |
| 1.7 | 1.7 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 1.7 | 5.0 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 1.7 | 1.7 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 1.7 | 3.3 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 1.6 | 4.9 | GO:0060023 | soft palate development(GO:0060023) |
| 1.6 | 4.9 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 1.6 | 18.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 1.6 | 14.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 1.6 | 4.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.6 | 16.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 1.6 | 11.2 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 1.6 | 25.6 | GO:0006491 | N-glycan processing(GO:0006491) |
| 1.6 | 22.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 1.6 | 6.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 1.6 | 6.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 1.6 | 3.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 1.6 | 3.1 | GO:0006497 | protein lipidation(GO:0006497) |
| 1.6 | 6.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.5 | 4.6 | GO:0035973 | aggrephagy(GO:0035973) |
| 1.5 | 1.5 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 1.5 | 1.5 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 1.5 | 3.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.5 | 9.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 1.5 | 9.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 1.5 | 4.6 | GO:0098885 | modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 1.5 | 1.5 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
| 1.5 | 4.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.5 | 4.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.5 | 7.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.5 | 4.5 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 1.5 | 7.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 1.5 | 8.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 1.5 | 1.5 | GO:0061205 | paramesonephric duct development(GO:0061205) |
| 1.5 | 4.4 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 1.5 | 1.5 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 1.5 | 1.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 1.5 | 5.8 | GO:0097393 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 1.5 | 5.8 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.5 | 5.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 1.5 | 1.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 1.5 | 5.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 1.4 | 2.9 | GO:0021764 | amygdala development(GO:0021764) |
| 1.4 | 4.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 1.4 | 7.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 1.4 | 4.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.4 | 12.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 1.4 | 4.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.4 | 10.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 1.4 | 2.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.4 | 4.2 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
| 1.4 | 21.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 1.4 | 2.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 1.4 | 1.4 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 1.4 | 27.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 1.4 | 4.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.4 | 4.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 1.4 | 1.4 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.4 | 2.7 | GO:0046541 | saliva secretion(GO:0046541) |
| 1.4 | 4.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 1.4 | 5.4 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 1.3 | 2.7 | GO:0002842 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.3 | 5.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.3 | 6.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 1.3 | 8.0 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 1.3 | 2.7 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 1.3 | 18.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 1.3 | 4.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 1.3 | 6.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 1.3 | 4.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.3 | 5.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.3 | 9.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.3 | 23.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 1.3 | 2.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.3 | 2.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.3 | 1.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 1.3 | 3.9 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.3 | 3.9 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 1.3 | 10.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 1.3 | 11.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 1.3 | 7.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.3 | 33.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 1.3 | 16.5 | GO:1990403 | embryonic brain development(GO:1990403) |
| 1.3 | 6.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.3 | 25.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 1.3 | 3.8 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 1.3 | 5.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 1.2 | 1.2 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 1.2 | 7.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 1.2 | 2.5 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) drug export(GO:0046618) |
| 1.2 | 4.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.2 | 2.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.2 | 3.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 1.2 | 6.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 1.2 | 9.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
| 1.2 | 6.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 1.2 | 4.8 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 1.2 | 8.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 1.2 | 6.0 | GO:0021592 | fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 1.2 | 30.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 1.2 | 4.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.2 | 1.2 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.2 | 2.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 1.2 | 2.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.2 | 16.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 1.2 | 2.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.2 | 1.2 | GO:1905165 | regulation of lysosomal protein catabolic process(GO:1905165) |
| 1.2 | 20.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 1.2 | 2.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 1.2 | 13.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.2 | 7.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 1.2 | 3.5 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.2 | 7.0 | GO:0030242 | pexophagy(GO:0030242) |
| 1.2 | 5.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 1.2 | 5.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 1.2 | 20.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 1.2 | 2.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.2 | 3.5 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 1.1 | 4.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.1 | 3.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 1.1 | 16.0 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 1.1 | 1.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.1 | 7.9 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 1.1 | 5.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 1.1 | 12.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 1.1 | 2.3 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 1.1 | 16.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 1.1 | 5.6 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 1.1 | 1.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.1 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
| 1.1 | 3.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 1.1 | 4.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 1.1 | 5.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.1 | 8.9 | GO:0007616 | long-term memory(GO:0007616) |
| 1.1 | 2.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 1.1 | 6.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 1.1 | 3.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 1.1 | 40.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 1.1 | 4.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 1.1 | 13.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 1.1 | 3.3 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
| 1.1 | 24.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 1.1 | 6.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 1.1 | 14.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 1.1 | 3.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 1.1 | 4.3 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.1 | 14.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 1.1 | 31.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 1.1 | 3.2 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.1 | 8.6 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 1.1 | 4.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.1 | 2.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.1 | 6.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 1.1 | 8.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 1.1 | 12.7 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 1.1 | 19.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
| 1.1 | 3.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 1.0 | 12.6 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.0 | 3.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
| 1.0 | 17.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 1.0 | 2.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.0 | 7.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 1.0 | 4.1 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.0 | 2.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 1.0 | 3.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 1.0 | 6.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 1.0 | 7.2 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 1.0 | 1.0 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 1.0 | 22.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 1.0 | 1.0 | GO:0090148 | membrane fission(GO:0090148) |
| 1.0 | 3.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 1.0 | 9.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 1.0 | 15.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 1.0 | 135.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 1.0 | 5.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 1.0 | 3.0 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 1.0 | 5.0 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.0 | 5.0 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.0 | 1.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 1.0 | 3.0 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 1.0 | 10.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.0 | 2.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.0 | 2.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 1.0 | 3.9 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
| 1.0 | 2.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.0 | 53.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 1.0 | 3.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.0 | 4.8 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 1.0 | 31.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 1.0 | 2.9 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.0 | 15.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.9 | 26.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.9 | 2.8 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.9 | 1.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.9 | 4.7 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.9 | 8.4 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.9 | 0.9 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.9 | 0.9 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 0.9 | 3.7 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.9 | 3.7 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.9 | 0.9 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.9 | 21.0 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.9 | 15.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.9 | 3.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.9 | 9.0 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.9 | 1.8 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.9 | 7.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.9 | 9.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.9 | 3.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.9 | 6.3 | GO:0045056 | transcytosis(GO:0045056) |
| 0.9 | 0.9 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.9 | 5.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.9 | 3.6 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
| 0.9 | 3.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.9 | 0.9 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
| 0.9 | 1.8 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.9 | 6.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.9 | 1.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.9 | 1.7 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 0.9 | 5.2 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.9 | 23.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.9 | 1.7 | GO:0072053 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.9 | 3.4 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.9 | 6.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.9 | 6.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.9 | 0.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.9 | 3.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.8 | 7.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.8 | 17.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.8 | 0.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.8 | 4.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.8 | 2.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.8 | 1.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.8 | 16.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.8 | 0.8 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.8 | 13.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.8 | 17.8 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
| 0.8 | 55.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.8 | 2.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.8 | 3.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.8 | 2.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.8 | 7.9 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.8 | 2.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.8 | 1.6 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.8 | 8.7 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
| 0.8 | 3.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.8 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.8 | 1.6 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.8 | 6.9 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.8 | 6.9 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.8 | 1.5 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.8 | 2.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.8 | 2.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.8 | 2.3 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.8 | 0.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
| 0.8 | 22.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.8 | 3.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.8 | 0.8 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.8 | 3.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.7 | 1.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.7 | 5.2 | GO:0051938 | L-glutamate import(GO:0051938) |
| 0.7 | 5.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
| 0.7 | 3.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.7 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.7 | 2.2 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.7 | 1.5 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.7 | 4.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.7 | 34.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.7 | 5.2 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.7 | 2.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.7 | 19.1 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.7 | 3.7 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.7 | 4.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.7 | 2.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.7 | 1.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.7 | 1.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.7 | 0.7 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.7 | 2.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.7 | 7.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.7 | 5.7 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.7 | 1.4 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.7 | 4.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.7 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.7 | 18.3 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.7 | 12.7 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.7 | 1.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.7 | 4.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.7 | 5.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.7 | 4.9 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.7 | 2.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.7 | 1.4 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.7 | 2.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.7 | 2.7 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.7 | 0.7 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.7 | 7.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.7 | 6.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.7 | 12.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.7 | 2.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.7 | 2.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.7 | 4.1 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.7 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
| 0.7 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.7 | 5.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.7 | 1.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.7 | 3.4 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.7 | 10.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.7 | 2.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.7 | 2.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.7 | 4.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.7 | 4.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.7 | 3.9 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.7 | 6.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.6 | 40.3 | GO:0006906 | vesicle fusion(GO:0006906) |
| 0.6 | 3.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.6 | 3.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.6 | 4.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.6 | 1.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.6 | 1.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 | 3.8 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.6 | 3.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.6 | 5.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.6 | 0.6 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.6 | 3.7 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.6 | 0.6 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 0.6 | 6.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.6 | 2.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.6 | 17.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.6 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.6 | 10.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.6 | 1.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.6 | 6.7 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.6 | 1.8 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
| 0.6 | 1.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.6 | 15.5 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.6 | 11.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.6 | 1.8 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.6 | 2.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.6 | 0.6 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.6 | 2.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
| 0.6 | 1.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.6 | 2.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.6 | 1.7 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.6 | 5.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.6 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 | 1.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.6 | 1.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.6 | 6.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.6 | 1.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.6 | 5.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.6 | 1.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.6 | 25.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.6 | 2.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.6 | 9.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.6 | 2.8 | GO:0006983 | ER overload response(GO:0006983) |
| 0.6 | 1.7 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.6 | 1.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.6 | 2.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.6 | 7.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.6 | 2.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.5 | 6.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.5 | 3.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.5 | 5.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.5 | 5.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.5 | 1.1 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.5 | 4.9 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.5 | 2.2 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.5 | 1.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.5 | 1.1 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.5 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.5 | 1.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.5 | 0.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 2.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.5 | 41.1 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.5 | 1.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.5 | 1.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.5 | 5.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.5 | 1.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.5 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.5 | 13.3 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.5 | 2.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.5 | 3.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.5 | 1.5 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.5 | 8.1 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.5 | 2.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.5 | 1.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.5 | 1.5 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.5 | 4.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 2.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.5 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.5 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.5 | 1.5 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.5 | 1.5 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.5 | 5.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.5 | 1.0 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.5 | 0.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.5 | 2.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 1.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.5 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.5 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 | 5.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.5 | 0.5 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.5 | 1.4 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.5 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.5 | 0.9 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.5 | 0.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.5 | 5.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.5 | 6.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.5 | 2.3 | GO:0044829 | positive regulation by host of viral process(GO:0044794) positive regulation by host of viral genome replication(GO:0044829) |
| 0.5 | 2.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.5 | 3.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.5 | 1.4 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.5 | 2.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.5 | 0.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.5 | 1.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.5 | 2.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.5 | 1.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.5 | 10.5 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.5 | 1.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.5 | 8.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.5 | 0.5 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.4 | 3.6 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.4 | 7.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.4 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.4 | 2.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.4 | 1.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.4 | 9.6 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.4 | 1.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.4 | 0.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.4 | 22.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.4 | 3.5 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.4 | 3.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.4 | 2.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
| 0.4 | 2.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 3.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.4 | 4.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.4 | 1.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 | 16.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.4 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 3.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.4 | 5.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.4 | 10.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.4 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.4 | 2.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.4 | 2.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.4 | 1.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.4 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.4 | 0.8 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.4 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.4 | 0.8 | GO:1901658 | glycosyl compound catabolic process(GO:1901658) |
| 0.4 | 2.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.4 | 0.8 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
| 0.4 | 6.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.4 | 1.2 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.4 | 2.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 | 0.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.4 | 2.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.4 | 6.0 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.4 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.4 | 3.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.4 | 3.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.4 | 0.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.4 | 7.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.4 | 1.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.4 | 1.9 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.4 | 1.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.4 | 5.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.4 | 3.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.4 | 1.5 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.4 | 2.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 | 1.5 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.4 | 1.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.4 | 2.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.4 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.4 | 1.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.4 | 0.4 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.4 | 0.4 | GO:0071380 | cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.4 | 1.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.4 | 1.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 | 0.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.4 | 1.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 | 3.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.4 | 2.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.4 | 1.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 | 1.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.4 | 2.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.4 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.4 | 4.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.4 | 0.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.4 | 0.7 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.4 | 2.5 | GO:0033622 | integrin activation(GO:0033622) |
| 0.4 | 6.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.3 | 2.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.3 | 1.7 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.3 | 6.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.3 | 1.4 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.3 | 4.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.3 | 2.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.3 | 0.7 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.3 | 3.7 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.3 | 0.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.3 | 4.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.3 | 2.0 | GO:0009301 | snRNA transcription(GO:0009301) |
| 0.3 | 1.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 | 0.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.3 | 2.6 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.3 | 2.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.3 | 1.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
| 0.3 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.3 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 2.6 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
| 0.3 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.3 | 2.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 3.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 0.9 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 | 0.9 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.3 | 1.2 | GO:0034312 | diol biosynthetic process(GO:0034312) |
| 0.3 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 5.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.3 | 0.9 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 | 1.5 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 | 2.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.3 | 1.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.3 | 1.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.3 | 0.9 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
| 0.3 | 7.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.3 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.3 | 5.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 2.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.3 | 0.9 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 | 0.9 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.3 | 1.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 | 4.6 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.3 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.3 | 2.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.3 | 3.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.3 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.3 | 3.4 | GO:0036503 | ERAD pathway(GO:0036503) |
| 0.3 | 0.8 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 1.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.3 | 0.8 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.3 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.3 | 1.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.3 | 1.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.3 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 0.8 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.3 | 2.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.3 | 1.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.3 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 | 9.0 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
| 0.3 | 27.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.3 | 0.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.3 | 2.9 | GO:0019835 | cytolysis(GO:0019835) |
| 0.3 | 1.8 | GO:0015862 | uridine transport(GO:0015862) |
| 0.3 | 1.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.3 | 0.5 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 0.3 | 1.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.3 | 2.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.3 | 1.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 1.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.3 | 2.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.3 | 2.8 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 | 0.2 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
| 0.2 | 0.7 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.2 | 4.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 1.9 | GO:0007032 | endosome organization(GO:0007032) |
| 0.2 | 1.0 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.2 | 0.5 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
| 0.2 | 1.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.2 | 0.9 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.2 | 0.7 | GO:0015824 | proline transport(GO:0015824) |
| 0.2 | 0.7 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 0.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.2 | 0.9 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 | 0.9 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 1.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 2.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.2 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.2 | 1.7 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 | 1.4 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.2 | 4.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 | 0.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.2 | 1.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.2 | 2.3 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.2 | 4.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.2 | 2.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.2 | 2.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 1.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.2 | 2.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.2 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 0.7 | GO:0070076 | histone lysine demethylation(GO:0070076) |
| 0.2 | 0.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 | 1.6 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 2.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.2 | 0.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 | 1.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 2.6 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.2 | 1.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.2 | 0.2 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 0.8 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 | 1.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 1.0 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 | 1.7 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.2 | 0.9 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 | 0.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.2 | 0.8 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.7 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.1 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 1.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.1 | 1.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.1 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.8 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.1 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.1 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.4 | GO:0035646 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 1.3 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.1 | 0.1 | GO:0080144 | lysine transport(GO:0015819) amino acid homeostasis(GO:0080144) |
| 0.1 | 1.0 | GO:0072010 | glomerular epithelium development(GO:0072010) |
| 0.1 | 2.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 1.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
| 0.1 | 4.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 1.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 1.1 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
| 0.1 | 0.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.4 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 3.3 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.1 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
| 0.1 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 1.9 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.1 | 3.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 1.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.1 | 0.7 | GO:0006188 | IMP biosynthetic process(GO:0006188) purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
| 0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.1 | 3.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 0.2 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
| 0.1 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 | 0.2 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) |
| 0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.7 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 0.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 0.5 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.1 | 1.4 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.1 | 0.3 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.1 | 0.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 | 0.3 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 | 0.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
| 0.1 | 0.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 | 1.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.3 | GO:0051095 | regulation of helicase activity(GO:0051095) |
| 0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 1.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.9 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
| 0.1 | 0.2 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.2 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.1 | 0.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 2.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 0.2 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.0 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 3.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.0 | 0.1 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.0 | 1.4 | GO:0098840 | protein transport along microtubule(GO:0098840) |
| 0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
| 0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 0.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.0 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 | 0.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.0 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
| 0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.0 | 0.1 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
| 0.0 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.0 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.0 | 0.1 | GO:0032309 | icosanoid secretion(GO:0032309) arachidonic acid secretion(GO:0050482) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) arachidonate transport(GO:1903963) |
| 0.0 | 0.1 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.0 | 0.2 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.9 | 77.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 12.8 | 38.3 | GO:0098855 | HCN channel complex(GO:0098855) |
| 11.7 | 35.1 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
| 11.4 | 34.2 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
| 10.4 | 51.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 9.8 | 9.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 7.3 | 43.9 | GO:0005955 | calcineurin complex(GO:0005955) |
| 7.3 | 43.7 | GO:0008091 | spectrin(GO:0008091) |
| 6.8 | 20.5 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 6.7 | 20.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 5.9 | 17.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 5.7 | 73.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 5.4 | 54.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 5.3 | 53.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 5.3 | 15.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 5.1 | 30.5 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 5.0 | 14.9 | GO:0044194 | cytolytic granule(GO:0044194) |
| 4.9 | 14.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 4.8 | 14.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 4.6 | 13.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 4.5 | 185.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 4.4 | 17.5 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 4.3 | 17.3 | GO:0044307 | dendritic branch(GO:0044307) |
| 4.2 | 20.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 3.9 | 19.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 3.7 | 119.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 3.7 | 70.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 3.7 | 14.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 3.6 | 104.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 3.4 | 47.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 3.2 | 141.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 3.1 | 12.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 3.1 | 130.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 3.0 | 18.1 | GO:0000322 | storage vacuole(GO:0000322) |
| 3.0 | 9.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 3.0 | 5.9 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 2.8 | 8.5 | GO:0071203 | WASH complex(GO:0071203) |
| 2.8 | 8.4 | GO:0032437 | cuticular plate(GO:0032437) |
| 2.8 | 11.2 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 2.8 | 13.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 2.7 | 8.2 | GO:0043293 | apoptosome(GO:0043293) |
| 2.7 | 35.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 2.4 | 17.1 | GO:0070695 | FHF complex(GO:0070695) |
| 2.4 | 36.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 2.4 | 38.5 | GO:0030673 | axolemma(GO:0030673) |
| 2.3 | 63.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 2.2 | 20.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 2.2 | 33.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 2.2 | 40.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 2.2 | 6.6 | GO:0005940 | septin ring(GO:0005940) |
| 2.2 | 135.3 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 2.2 | 8.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 2.2 | 4.3 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 2.1 | 2.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 2.1 | 6.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 2.1 | 20.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 2.0 | 160.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 1.9 | 13.6 | GO:0005883 | neurofilament(GO:0005883) |
| 1.9 | 408.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 1.9 | 3.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 1.9 | 75.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 1.9 | 5.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 1.9 | 7.6 | GO:0044327 | dendritic spine head(GO:0044327) |
| 1.9 | 11.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 1.9 | 11.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 1.9 | 1.9 | GO:0045177 | apical part of cell(GO:0045177) |
| 1.8 | 57.0 | GO:0051233 | spindle midzone(GO:0051233) |
| 1.8 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.8 | 7.3 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.8 | 1.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.8 | 14.2 | GO:0097413 | Lewy body(GO:0097413) |
| 1.8 | 7.0 | GO:0032280 | symmetric synapse(GO:0032280) |
| 1.7 | 1.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 1.7 | 19.9 | GO:0005902 | microvillus(GO:0005902) |
| 1.7 | 24.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 1.6 | 4.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 1.6 | 19.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.6 | 16.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.6 | 40.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 1.6 | 77.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 1.6 | 4.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 1.6 | 4.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.6 | 12.7 | GO:0034704 | calcium channel complex(GO:0034704) |
| 1.6 | 6.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 1.6 | 3.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.6 | 7.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 1.6 | 73.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 1.5 | 15.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 1.5 | 12.2 | GO:0042382 | paraspeckles(GO:0042382) |
| 1.5 | 8.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 1.5 | 101.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 1.5 | 4.5 | GO:0031417 | NatC complex(GO:0031417) |
| 1.5 | 4.4 | GO:0097433 | dense body(GO:0097433) |
| 1.5 | 5.9 | GO:0030891 | VCB complex(GO:0030891) |
| 1.5 | 1.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 1.5 | 5.8 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 1.5 | 10.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 1.4 | 4.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 1.4 | 2.9 | GO:0030870 | Mre11 complex(GO:0030870) |
| 1.4 | 29.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 1.4 | 16.9 | GO:0043196 | varicosity(GO:0043196) |
| 1.4 | 13.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 1.4 | 1.4 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 1.4 | 16.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 1.3 | 4.0 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.3 | 13.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 1.3 | 5.1 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 1.3 | 20.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 1.3 | 17.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 1.2 | 1.2 | GO:0030690 | Noc complex(GO:0030689) Noc1p-Noc2p complex(GO:0030690) |
| 1.2 | 4.9 | GO:0031045 | dense core granule(GO:0031045) |
| 1.2 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 1.2 | 68.5 | GO:0043195 | terminal bouton(GO:0043195) |
| 1.2 | 21.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 1.2 | 10.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.2 | 2.4 | GO:0043512 | inhibin A complex(GO:0043512) |
| 1.2 | 6.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 1.2 | 2.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 1.2 | 31.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 1.2 | 15.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.2 | 7.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 1.2 | 2.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.2 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 1.2 | 19.6 | GO:0000124 | SAGA complex(GO:0000124) |
| 1.2 | 4.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 1.1 | 58.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 1.1 | 10.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 1.1 | 7.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 1.1 | 2.2 | GO:1903349 | omegasome membrane(GO:1903349) |
| 1.1 | 3.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 1.1 | 6.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 1.1 | 17.9 | GO:0097228 | sperm principal piece(GO:0097228) |
| 1.0 | 7.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 1.0 | 3.1 | GO:0032590 | dendrite membrane(GO:0032590) |
| 1.0 | 10.1 | GO:0032982 | myosin filament(GO:0032982) |
| 1.0 | 1.0 | GO:0002141 | stereocilia ankle link(GO:0002141) |
| 1.0 | 4.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 1.0 | 4.9 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.0 | 20.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 1.0 | 156.4 | GO:0014069 | postsynaptic density(GO:0014069) |
| 1.0 | 4.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.0 | 11.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.9 | 1.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.9 | 10.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.9 | 2.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.9 | 8.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.9 | 10.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.9 | 4.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.9 | 8.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.9 | 25.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.8 | 2.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.8 | 6.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.8 | 4.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.8 | 81.1 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.8 | 15.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.8 | 4.8 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.8 | 7.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.8 | 63.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.8 | 5.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.8 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.8 | 35.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
| 0.8 | 4.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.8 | 16.6 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.7 | 5.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.7 | 138.3 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.7 | 25.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.7 | 2.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.7 | 3.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.7 | 33.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.7 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.7 | 2.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.7 | 2.8 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 0.7 | 42.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.7 | 16.1 | GO:0032420 | stereocilium(GO:0032420) |
| 0.7 | 4.2 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.7 | 9.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.7 | 3.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.7 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.7 | 6.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.7 | 6.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.7 | 2.7 | GO:0005921 | gap junction(GO:0005921) |
| 0.7 | 0.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.7 | 9.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.6 | 27.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.6 | 24.9 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.6 | 3.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.6 | 3.8 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.6 | 5.6 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.6 | 292.4 | GO:0005768 | endosome(GO:0005768) |
| 0.6 | 3.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.6 | 2.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.6 | 14.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.6 | 1.8 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.6 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.6 | 4.2 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.6 | 21.3 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.6 | 2.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.6 | 1.8 | GO:0071920 | cleavage body(GO:0071920) |
| 0.6 | 13.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.6 | 3.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.6 | 1.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.6 | 18.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.5 | 1.6 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.5 | 8.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.5 | 3.2 | GO:0042641 | actomyosin(GO:0042641) |
| 0.5 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.5 | 3.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.5 | 12.8 | GO:0005903 | brush border(GO:0005903) |
| 0.5 | 14.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.5 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.5 | 2.6 | GO:0038201 | TOR complex(GO:0038201) |
| 0.5 | 5.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.5 | 3.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.5 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.5 | 1.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.5 | 4.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.5 | 2.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.5 | 4.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.5 | 18.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.5 | 2.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.5 | 4.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.5 | 1.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.5 | 9.5 | GO:0002102 | podosome(GO:0002102) |
| 0.5 | 1.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.5 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.5 | 4.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.5 | 6.0 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.5 | 1.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.5 | 10.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.5 | 1.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.5 | 8.2 | GO:0043679 | axon terminus(GO:0043679) |
| 0.5 | 2.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.4 | 27.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.4 | 0.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.4 | 46.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.4 | 2.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.4 | 1.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.4 | 1.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 22.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.4 | 32.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.4 | 0.8 | GO:0034657 | GID complex(GO:0034657) |
| 0.4 | 1.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 4.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.4 | 8.2 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
| 0.4 | 69.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.4 | 10.8 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.4 | 3.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.4 | 6.0 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.4 | 2.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.4 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.4 | 2.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 2.6 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.4 | 10.8 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.4 | 1.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.4 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.4 | 4.6 | GO:0000145 | exocyst(GO:0000145) |
| 0.4 | 25.3 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.4 | 9.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.4 | 7.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.4 | 58.2 | GO:0005773 | vacuole(GO:0005773) |
| 0.3 | 3.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.3 | 11.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.3 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.3 | 3.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.3 | 2.4 | GO:0005884 | actin filament(GO:0005884) |
| 0.3 | 8.8 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.3 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 1.0 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
| 0.3 | 4.5 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.3 | 10.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.3 | 9.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.3 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.3 | 1.5 | GO:0097361 | CIA complex(GO:0097361) |
| 0.3 | 19.4 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.3 | 2.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 10.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.3 | 4.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.3 | 6.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.3 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
| 0.3 | 63.5 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
| 0.3 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.3 | 806.3 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.3 | 5.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.3 | 2.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.3 | 1.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 8.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 1.7 | GO:0031430 | M band(GO:0031430) |
| 0.3 | 11.8 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.3 | 0.8 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.3 | 1.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.3 | 1.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 1.5 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.3 | 0.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 1.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 3.2 | GO:1990752 | microtubule end(GO:1990752) |
| 0.2 | 5.8 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 1.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 1.0 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 1.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
| 0.2 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 0.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 23.0 | GO:0044297 | cell body(GO:0044297) |
| 0.1 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 9.0 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 27.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.1 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 0.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 1.9 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
| 0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.1 | 2.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 1.4 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 2.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 1.2 | GO:0005938 | cell cortex(GO:0005938) |
| 0.0 | 1.2 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 3.1 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.4 | GO:0030496 | midbody(GO:0030496) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.5 | 50.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 12.3 | 49.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 9.9 | 29.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 9.9 | 39.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 9.7 | 29.0 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 8.4 | 50.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 8.1 | 56.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 7.9 | 23.6 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
| 7.6 | 45.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 7.4 | 22.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 7.4 | 37.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 7.1 | 21.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 6.9 | 27.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 6.9 | 27.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 6.8 | 47.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 6.7 | 33.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 6.5 | 19.4 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 6.5 | 6.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 6.5 | 38.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 6.5 | 38.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 6.0 | 24.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 6.0 | 23.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 6.0 | 23.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 5.9 | 41.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 5.9 | 52.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 5.6 | 16.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 5.2 | 20.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 5.2 | 57.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 5.1 | 15.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 5.0 | 54.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 4.7 | 18.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 4.7 | 14.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 4.6 | 18.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 4.5 | 17.8 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 4.4 | 31.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 4.4 | 39.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 4.3 | 25.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 4.3 | 69.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 4.3 | 25.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 4.3 | 17.1 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 4.3 | 17.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 4.1 | 24.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 4.1 | 24.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 4.1 | 24.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 4.1 | 28.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 4.0 | 16.0 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 3.9 | 7.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 3.8 | 15.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 3.8 | 11.3 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 3.7 | 11.0 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 3.6 | 18.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 3.5 | 10.5 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 3.5 | 10.4 | GO:0019002 | GMP binding(GO:0019002) |
| 3.5 | 17.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 3.4 | 61.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 3.4 | 30.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 3.4 | 17.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 3.4 | 20.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 3.3 | 72.5 | GO:0043274 | phospholipase binding(GO:0043274) |
| 3.3 | 52.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 3.3 | 13.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 3.2 | 9.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 3.2 | 19.2 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 3.2 | 15.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 3.1 | 81.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 3.1 | 12.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 3.0 | 33.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 2.9 | 8.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 2.9 | 23.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 2.9 | 20.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 2.9 | 17.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 2.9 | 31.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 2.8 | 22.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 2.8 | 55.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 2.8 | 30.6 | GO:0031005 | filamin binding(GO:0031005) |
| 2.8 | 22.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 2.7 | 10.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.7 | 13.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 2.7 | 10.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 2.7 | 16.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 2.7 | 139.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 2.7 | 10.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 2.7 | 21.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 2.6 | 10.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 2.6 | 13.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 2.6 | 7.9 | GO:0031208 | POZ domain binding(GO:0031208) |
| 2.6 | 18.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 2.6 | 15.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 2.6 | 2.6 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 2.6 | 25.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 2.5 | 20.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 2.5 | 22.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 2.5 | 7.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 2.5 | 12.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 2.5 | 9.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 2.4 | 14.7 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
| 2.4 | 9.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 2.4 | 7.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 2.4 | 2.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 2.4 | 33.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 2.3 | 25.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 2.3 | 11.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 2.3 | 7.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 2.3 | 11.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 2.3 | 6.9 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 2.3 | 13.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 2.3 | 6.9 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 2.3 | 25.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 2.3 | 2.3 | GO:0048185 | activin binding(GO:0048185) |
| 2.3 | 38.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 2.3 | 20.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 2.2 | 31.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 2.2 | 6.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 2.2 | 15.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 2.2 | 21.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 2.1 | 8.5 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 2.1 | 25.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 2.1 | 6.2 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 2.1 | 2.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 2.1 | 6.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 2.0 | 30.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 2.0 | 12.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 2.0 | 103.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 2.0 | 2.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 2.0 | 7.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 2.0 | 15.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 2.0 | 3.9 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 1.9 | 5.8 | GO:0097016 | L27 domain binding(GO:0097016) |
| 1.9 | 11.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 1.9 | 13.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 1.9 | 26.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 1.9 | 11.4 | GO:0097001 | ceramide binding(GO:0097001) |
| 1.9 | 11.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 1.8 | 5.5 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 1.8 | 5.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 1.8 | 71.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 1.8 | 12.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 1.8 | 5.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.8 | 25.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 1.8 | 3.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.8 | 1.8 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 1.8 | 10.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.8 | 38.6 | GO:0031489 | myosin V binding(GO:0031489) |
| 1.7 | 8.7 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 1.7 | 13.9 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.7 | 5.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.7 | 18.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 1.7 | 8.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 1.6 | 6.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 1.6 | 9.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 1.6 | 9.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 1.6 | 4.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.6 | 12.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 1.6 | 9.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.6 | 7.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 1.6 | 15.7 | GO:0043495 | protein anchor(GO:0043495) |
| 1.6 | 21.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 1.5 | 6.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 1.5 | 67.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 1.5 | 4.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 1.5 | 6.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 1.5 | 10.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 1.5 | 4.4 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 1.5 | 13.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 1.5 | 8.8 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
| 1.5 | 16.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 1.5 | 23.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 1.5 | 36.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.5 | 18.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.4 | 4.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 1.4 | 5.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 1.4 | 4.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.4 | 7.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.4 | 137.0 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 1.4 | 15.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.4 | 6.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 1.4 | 1.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 1.4 | 16.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 1.4 | 1.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 1.3 | 12.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.3 | 6.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.3 | 4.0 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 1.3 | 51.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 1.3 | 23.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 1.3 | 18.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 1.3 | 11.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 1.3 | 3.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.3 | 2.6 | GO:2001070 | starch binding(GO:2001070) |
| 1.3 | 2.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.3 | 3.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 1.3 | 8.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.3 | 6.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 1.3 | 2.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 1.3 | 8.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 1.3 | 6.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.2 | 1.2 | GO:0008061 | chitin binding(GO:0008061) |
| 1.2 | 11.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 1.2 | 3.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 1.2 | 18.1 | GO:0031402 | sodium ion binding(GO:0031402) |
| 1.2 | 10.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.2 | 9.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 1.2 | 9.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.2 | 3.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.2 | 5.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 1.2 | 7.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 1.2 | 32.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 1.2 | 2.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 1.2 | 9.4 | GO:0005267 | potassium channel activity(GO:0005267) |
| 1.2 | 5.8 | GO:0055100 | adiponectin binding(GO:0055100) |
| 1.2 | 17.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 1.2 | 6.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.2 | 6.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 1.2 | 4.6 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 1.1 | 24.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 1.1 | 3.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.1 | 6.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 1.1 | 14.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 1.1 | 3.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 1.1 | 6.7 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.1 | 3.3 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 1.1 | 2.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 1.1 | 18.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 1.1 | 31.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 1.1 | 6.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 1.1 | 155.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 1.1 | 5.3 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 1.0 | 5.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 1.0 | 19.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 1.0 | 4.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 1.0 | 7.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 1.0 | 30.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 1.0 | 81.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 1.0 | 18.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.0 | 5.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.0 | 11.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.0 | 4.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 1.0 | 8.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 1.0 | 31.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 1.0 | 20.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 1.0 | 20.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 1.0 | 5.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
| 1.0 | 3.0 | GO:2001069 | glycogen binding(GO:2001069) |
| 1.0 | 42.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 1.0 | 4.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 1.0 | 7.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 1.0 | 6.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 1.0 | 13.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 1.0 | 19.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 1.0 | 2.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.0 | 4.8 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 1.0 | 4.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 1.0 | 13.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 1.0 | 4.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.0 | 2.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 1.0 | 8.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 1.0 | 37.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 1.0 | 41.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 1.0 | 31.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.9 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.9 | 23.5 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.9 | 2.8 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.9 | 53.9 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.9 | 18.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.9 | 2.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.9 | 3.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.9 | 2.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.9 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.9 | 2.7 | GO:0043559 | insulin binding(GO:0043559) |
| 0.9 | 7.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.9 | 2.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.9 | 3.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.9 | 3.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.9 | 2.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.9 | 3.5 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.9 | 18.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.8 | 2.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.8 | 24.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.8 | 3.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.8 | 20.6 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.8 | 5.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.8 | 4.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.8 | 9.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.8 | 11.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.8 | 5.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.8 | 2.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.8 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.8 | 6.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.8 | 2.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) |
| 0.8 | 4.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.8 | 5.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.8 | 21.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.8 | 15.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.8 | 14.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.8 | 6.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.8 | 35.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.8 | 0.8 | GO:0004663 | protein farnesyltransferase activity(GO:0004660) Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.8 | 3.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.7 | 19.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.7 | 2.2 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
| 0.7 | 5.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.7 | 2.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.7 | 2.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.7 | 8.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.7 | 3.7 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.7 | 4.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.7 | 9.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.7 | 2.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.7 | 5.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.7 | 11.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.7 | 3.6 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.7 | 338.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.7 | 2.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.7 | 9.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.7 | 13.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.7 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.7 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.7 | 2.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.7 | 4.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.7 | 2.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.7 | 16.0 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.7 | 2.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.7 | 3.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.7 | 2.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.7 | 1.4 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.7 | 3.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.7 | 4.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.7 | 3.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.7 | 7.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.7 | 2.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.7 | 4.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.7 | 3.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.7 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.7 | 11.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.7 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 9.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.6 | 14.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.6 | 42.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.6 | 2.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.6 | 4.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.6 | 7.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.6 | 4.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.6 | 3.8 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.6 | 24.6 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.6 | 2.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.6 | 3.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.6 | 1.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.6 | 32.6 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.6 | 9.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.6 | 1.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.6 | 5.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.6 | 4.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.6 | 15.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.6 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.6 | 15.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.6 | 2.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.6 | 102.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.6 | 3.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.6 | 6.9 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.6 | 106.0 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.6 | 17.2 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.6 | 13.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.6 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.6 | 25.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.6 | 5.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.5 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.5 | 10.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.5 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.5 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.5 | 1.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.5 | 1.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.5 | 2.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.5 | 2.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.5 | 2.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.5 | 1.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.5 | 1.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.5 | 13.3 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.5 | 1.0 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 0.5 | 10.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.5 | 6.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.5 | 3.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.5 | 10.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
| 0.5 | 6.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.5 | 41.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.5 | 5.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.5 | 6.8 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.5 | 2.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.5 | 0.9 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.5 | 2.4 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) nickel cation transmembrane transporter activity(GO:0015099) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.5 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.5 | 3.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.5 | 0.9 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.5 | 1.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.5 | 27.9 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.5 | 3.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.5 | 1.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.5 | 1.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.4 | 1.3 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.4 | 6.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.4 | 7.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.4 | 1.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.4 | 13.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.4 | 2.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 1.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 1.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.4 | 1.7 | GO:0005536 | glucose binding(GO:0005536) |
| 0.4 | 2.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.4 | 3.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.4 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.4 | 3.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.4 | 27.7 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.4 | 1.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.4 | 8.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.4 | 2.8 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.4 | 1.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.4 | 5.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.4 | 1.2 | GO:0045340 | mercury ion binding(GO:0045340) |
| 0.4 | 2.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.4 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.4 | 3.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.4 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.4 | 2.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.4 | 19.4 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
| 0.4 | 3.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.4 | 1.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.4 | 2.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.4 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.4 | 33.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.4 | 1.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.4 | 3.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.4 | 0.4 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.4 | 1.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.4 | 0.7 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.4 | 2.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 0.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.4 | 1.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.3 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.3 | 1.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.3 | 1.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 3.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.3 | 0.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.3 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.3 | 1.0 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
| 0.3 | 1.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.3 | 5.5 | GO:0022834 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
| 0.3 | 0.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 1.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.3 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.3 | 2.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.3 | 0.3 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.3 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.3 | 4.4 | GO:0048038 | quinone binding(GO:0048038) |
| 0.3 | 1.6 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.3 | 14.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.3 | 1.6 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.3 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 0.9 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.3 | 1.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 1.2 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.3 | 3.3 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.3 | 6.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.3 | 1.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.3 | 8.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.3 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.3 | 2.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.3 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.3 | 11.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.3 | 0.8 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
| 0.3 | 3.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.3 | 18.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.3 | 4.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.3 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.3 | 1.1 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.3 | 1.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.3 | 1.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.3 | 1.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.3 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.3 | 0.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.2 | 9.7 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 2.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 1.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.2 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.2 | 5.6 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.2 | 3.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.2 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.2 | 0.9 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.2 | 2.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 7.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 4.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.2 | 3.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.2 | 2.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 1.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.2 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.2 | 1.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.2 | 5.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 0.7 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
| 0.2 | 0.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 0.4 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.2 | 3.9 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.2 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.2 | 3.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.2 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 3.4 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.2 | 1.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.2 | 2.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 2.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 0.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 4.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.2 | 4.6 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
| 0.2 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 1.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 3.1 | GO:0071949 | FAD binding(GO:0071949) |
| 0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 0.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.2 | 1.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.2 | 3.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.2 | 1.0 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.2 | 2.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.2 | 0.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.2 | 9.1 | GO:0002020 | protease binding(GO:0002020) |
| 0.2 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.2 | 2.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.2 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.2 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 7.5 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 1.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 1.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.1 | 9.2 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.1 | 0.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 1.1 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 2.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.1 | 0.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
| 0.1 | 24.7 | GO:0003779 | actin binding(GO:0003779) |
| 0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
| 0.1 | 0.8 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 1.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 1.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 3.7 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.1 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.7 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.1 | 1.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.1 | 0.2 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 1.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 15.1 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.4 | GO:0023023 | MHC protein complex binding(GO:0023023) |
| 0.1 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 5.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 8.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.1 | 0.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 7.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.1 | 4.9 | GO:0016874 | ligase activity(GO:0016874) |
| 0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 0.2 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.1 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 12.5 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 0.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.1 | GO:0008311 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.0 | 0.1 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
| 0.0 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.0 | 1.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
| 0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.0 | 0.0 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
| 0.0 | 0.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.0 | 1.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.0 | 0.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.0 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.4 | 125.5 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 7.2 | 21.5 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 3.5 | 202.3 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 3.3 | 58.6 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 2.9 | 44.0 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 2.8 | 11.2 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 2.8 | 156.8 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 2.7 | 63.0 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 2.5 | 7.6 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 2.3 | 9.3 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
| 2.2 | 90.3 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 2.1 | 22.6 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 2.0 | 18.4 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 1.8 | 22.2 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 1.8 | 17.6 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 1.5 | 27.6 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 1.5 | 20.5 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 1.5 | 38.1 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 1.5 | 85.6 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 1.4 | 4.3 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 1.4 | 30.3 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 1.4 | 77.6 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 1.3 | 20.1 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.3 | 5.1 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 1.3 | 17.5 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 1.2 | 22.3 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 1.1 | 19.0 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 1.1 | 46.8 | PID_SHP2_PATHWAY | SHP2 signaling |
| 1.1 | 31.9 | PID_ARF_3PATHWAY | Arf1 pathway |
| 1.0 | 1.0 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 1.0 | 10.2 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 1.0 | 6.8 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.9 | 51.1 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.9 | 25.9 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.9 | 9.4 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.9 | 17.1 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.8 | 3.4 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.8 | 34.2 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.8 | 19.4 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.8 | 97.4 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.7 | 18.1 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.7 | 6.5 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.6 | 6.4 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.6 | 9.1 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.6 | 3.6 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.6 | 3.5 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.6 | 10.0 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.6 | 6.4 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 0.6 | 14.4 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.6 | 4.4 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.5 | 3.8 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.5 | 9.0 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.5 | 3.2 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.5 | 6.2 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.5 | 3.0 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.5 | 4.4 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.5 | 4.5 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.4 | 4.3 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.4 | 2.2 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.4 | 2.9 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.4 | 8.7 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.4 | 3.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.4 | 0.7 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 4.0 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.3 | 1.6 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.3 | 4.8 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.3 | 0.6 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
| 0.3 | 4.4 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.3 | 3.3 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 1.1 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.3 | 14.2 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.3 | 1.7 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.3 | 2.2 | PID_IL27_PATHWAY | IL27-mediated signaling events |
| 0.3 | 10.1 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.3 | 4.1 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 2.1 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.2 | 2.7 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 7.9 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
| 0.2 | 0.5 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 0.2 | 0.7 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 1.5 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 2.3 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 0.8 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 2.3 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 1.8 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.2 | 1.2 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 4.4 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 0.3 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 1.7 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 2.5 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.1 | 1.4 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.1 | 1.2 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 6.7 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.1 | 1.3 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 1.2 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 0.3 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.0 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 2.0 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 1.1 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.1 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.1 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.0 | 2.1 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.0 | 0.2 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.9 | 82.7 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 5.8 | 46.0 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 5.4 | 70.4 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 5.4 | 70.2 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 4.9 | 203.8 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 4.7 | 33.1 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 4.5 | 9.0 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 3.7 | 29.6 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 3.6 | 56.9 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 3.5 | 45.1 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 3.4 | 81.2 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 3.1 | 47.1 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 2.9 | 66.8 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 2.8 | 22.4 | REACTOME_PLC_BETA_MEDIATED_EVENTS | Genes involved in PLC beta mediated events |
| 2.8 | 89.0 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 2.7 | 60.5 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 2.7 | 54.2 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 2.7 | 56.8 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 2.6 | 94.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 2.5 | 73.9 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 2.5 | 64.0 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 2.5 | 24.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 2.4 | 14.6 | REACTOME_SOS_MEDIATED_SIGNALLING | Genes involved in SOS-mediated signalling |
| 2.4 | 57.6 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 2.4 | 7.2 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 2.3 | 7.0 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 2.3 | 6.9 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 2.1 | 6.3 | REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 2.0 | 16.4 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 2.0 | 25.5 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 2.0 | 9.8 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.9 | 13.3 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 1.9 | 7.6 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.9 | 26.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 1.9 | 67.6 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 1.8 | 5.4 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 1.7 | 17.2 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 1.7 | 1.7 | REACTOME_SIGNAL_AMPLIFICATION | Genes involved in Signal amplification |
| 1.6 | 3.3 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 1.6 | 1.6 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 1.6 | 17.5 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.6 | 26.5 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 1.6 | 10.9 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 1.5 | 12.3 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.5 | 39.1 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
| 1.5 | 22.6 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 1.5 | 4.5 | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | Genes involved in Prolonged ERK activation events |
| 1.5 | 58.0 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 1.5 | 51.5 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 1.5 | 33.7 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 1.5 | 1.5 | REACTOME_SEMAPHORIN_INTERACTIONS | Genes involved in Semaphorin interactions |
| 1.4 | 49.0 | REACTOME_ION_CHANNEL_TRANSPORT | Genes involved in Ion channel transport |
| 1.4 | 47.2 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 1.4 | 1.4 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
| 1.4 | 2.8 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.4 | 39.9 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 1.3 | 19.8 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 1.3 | 15.8 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 1.3 | 10.5 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 1.2 | 6.2 | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 1.2 | 7.4 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
| 1.2 | 1.2 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 1.2 | 28.6 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.2 | 10.6 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 1.2 | 2.3 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
| 1.1 | 53.8 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 1.1 | 6.8 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 1.1 | 13.5 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 1.1 | 41.9 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 1.1 | 7.7 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 1.1 | 12.0 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 1.1 | 36.9 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 1.1 | 2.2 | REACTOME_SHC_MEDIATED_SIGNALLING | Genes involved in SHC-mediated signalling |
| 1.1 | 75.4 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 1.1 | 28.9 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 1.0 | 9.4 | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 1.0 | 9.4 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 1.0 | 13.3 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 1.0 | 3.9 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 1.0 | 41.2 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.9 | 1.9 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.9 | 2.7 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.9 | 18.5 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.9 | 1.7 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.8 | 40.7 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.8 | 17.7 | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.8 | 5.6 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.8 | 24.4 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.8 | 18.5 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.8 | 9.2 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.8 | 9.1 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.7 | 11.6 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.7 | 4.4 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.7 | 4.8 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.7 | 0.7 | REACTOME_BOTULINUM_NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.7 | 19.7 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.7 | 2.7 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.7 | 6.0 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.6 | 9.0 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.6 | 7.6 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.6 | 7.8 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.6 | 9.3 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.6 | 48.3 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.6 | 5.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.5 | 12.8 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.5 | 2.6 | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.5 | 9.8 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.5 | 10.0 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 3.0 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.5 | 6.3 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 6.3 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.5 | 24.0 | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.5 | 20.0 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.5 | 6.2 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.5 | 18.4 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.5 | 9.9 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.5 | 9.7 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.5 | 10.9 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 2.2 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.4 | 2.2 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.4 | 11.6 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.4 | 2.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.4 | 4.5 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.4 | 14.3 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.4 | 3.6 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.4 | 4.0 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.4 | 2.8 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.4 | 3.2 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 3.9 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.4 | 12.5 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.4 | 2.3 | REACTOME_PKB_MEDIATED_EVENTS | Genes involved in PKB-mediated events |
| 0.4 | 2.7 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.4 | 25.6 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.4 | 1.8 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.4 | 4.0 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.4 | 11.8 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.3 | 9.4 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 0.3 | 3.1 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.3 | 0.7 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.3 | 3.3 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 9.3 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.3 | 2.8 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 3.9 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.3 | 9.7 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.3 | 1.1 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.3 | 4.2 | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.3 | 6.6 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.3 | 8.1 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.3 | 8.6 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 18.6 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.2 | 4.6 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 2.0 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 49.1 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 3.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 2.3 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 4.5 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 1.9 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 0.7 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.2 | 0.5 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 1.3 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 0.5 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.3 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.2 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 0.9 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 2.9 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 2.5 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 4.5 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 0.6 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 0.3 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.2 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.1 | 0.1 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.1 | 0.5 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 0.9 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
| 0.0 | 0.1 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 2.6 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.5 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
|
|
|